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Total hip arthroplasty for primary osteoarthroses in 
younger patients in the Finnish arthroplasty register 
Sir—Firstly, the Finnish Orthopaedic community 
should be complimented with this report of their 
experience with total hip arthroplasties in patients 
under 55 years. However, we would like to make 
some comments.
The report is based on 4,661 THAs performed in 
Finland in patients under 55 years of age with the 
diagnosis of primary osteoarthrosis. This is 45% 
of all THA implants in patients under 55, and the 
more difﬁcult hips are thus excluded. From the 
report, it is clear that the market for young patients 
in Finland is dominated by uncemented implants 
nowadays; in 2000–2001, 81% of the stems and 
88% of the cups were uncemented. The median 
follow-up time was 6.2 years. Considering this, 
the revision burden of 15% at that median follow-
up time is relatively high. The reason may be that 
many less favorable implants have been performed 
in the past.
In the introduction, the authors adopt the crite-
ria of the NICE (2003) report for a good long-term 
outcome of a hip prosthesis (> 90% survival rate of 
the whole implant at 10 years) and refer to some 
reports which claim to illustrate the excellent out-
come of (non)cemented hips. However, the reports 
cited do not fulﬁll the criteria of the NICE report. 
Indeed, the reports cited suggest an excellent sur-
vival of one of the components of a noncemented 
hip implant. However, patients beneﬁt from a 
total hip implant only if all the components of the 
implant survive at least 10 years. The survival rate 
of McLaughlin and Lee (2000) (44% at a mean of 
10.2 years), Aldinger et al. 2003 (78% at 12 years), 
and Capello et al. (2003) (54% at 14 years) clearly 
do not fulﬁll the NICE criteria. Although the 
reports cited by Kim et al. (2002, 2003) approach 
a minimum of 10 years survival, they still do not 
have the minimum 10-year survival rate. The cited 
report of Jacobsen et al. (2003) has neither the 
minimal follow-up nor the required outcome (83% 
survival at 8 years). References to available reports 
of cemented hip implants in the literature that do 
fulﬁll the NICE criteria for at least the minimal 10-
year follow-up are omitted. 
When the authors compare the outcome for 
stem ﬁxation (i.e. comparing cemented versus 
the noncemented concepts), they conclude that 
in the decade 1980–1990, survival of the nonce-
mented stems was better than cemented stems. 
In the period 1990–2000, however, there was no 
difference in survival rates between noncemented 
stems and cemented stems at the endpoint “revi-
sions of stem for any reason”. At this point in the 
discussion, the conclusions about cemented stems 
should have ended. However, the outcomes of the 
different types of noncemented stems are subse-
quently studied and compared to the overall group 
of cemented stems. This is not very realistic. Like 
noncemented stems, cemented stems have differ-
ent outcomes (Swedish and Norwegian Hip Regis-
ters). The reason why the authors compared differ-
ent types of noncemented stems with all cemented 
stems collected together in one group is unclear. 
Perhaps the number of different cemented stem 
designs was too small for comparison. Comparing 
the outcomes of the different types of noncemented 
stems individually should also be done with care; 
as is also concluded by the authors in the discus-
sion, the mean FU of the different types of stems 
differs by a factor of 3 (FU HA-coated uncemented 
3.4 years; ext. porous-coated 11 years).
Regarding cups, in the decade 1980–1990 the 
overall survival of cemented cups was better than 
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and 2000 the survival rates of cemented and non-
cemented cups were comparable.
Based on this very informative report, the con-
clusion should therefore be that the outcome in 
young patients for both cemented and nonce-
mented implants is still a problem, that the overall 
results of cemented versus noncemented stems in 
the last decade are comparable, that within the total 
group of noncemented stems, some designs have 
better outcomes than others, and that the outcome 
of modern noncemented cup designs is comparable 
to that of cemented all-polyethylene cups. 
The most important information in this report is, 
however, lacking—and that is the overall survival, 
including any reoperation for any reason, of each 
type of implant in these young patients. Patients 
only beneﬁt if all the components of an implant sur-
vive well. For example, in the Norwegian Register 
the Corail noncemented stem has an excellent sur-
vival rate of 15 years in young patients. Combined 
with a cup, it gave inferior results. Thus, looking 
at the overall survival of the total implant, the indi-
vidual patient obtained no beneﬁt from the stem 
and this is what really counts for the individual 
patient. The main question, therefore, is “has there 
been any combination of (non)cemented stems and 
(non)cemented cups implanted in patients which 
has a superior outcome and did this combination 
approach the requirements of the NICE criteria?” 
This would guide surgeons to use implants in 
young patients which really beneﬁt them as indi-
viduals.
BW Schreurs and JWM Gardeniers
Department of Orthopedics 800, PB 9101, NL-
6500 HB Nijmegen, the Netherlands
b. Schreurs@orthop.umcn.nl
Sir—We thank Drs. Schreurs and Gardeniers for 
their detailed analysis and comments. We wish to 
return the following comments.
It has been reported that THA for developmen-
tal dysplasia of the hip has poorer outcome than 
THA for osteoarthrosis; the importance of consid-
ering confounding factors in the survival analysis 
is obvious (Furnes et al. 2001). Thus, analyzing all 
diagnoses in younger patients as one group would 
not be scientiﬁcally valid. On the contrary, it would 
be absolutely conﬂicting.
As we have described in our article, orthopedic 
surgeons in Finland have paid dearly for experi-
menting with new, undocumented implants. For 
example, smooth-threaded uncemented cups and 
some uncoated uncemented stems appeared to be 
total catastrophes; common use of these inferior 
implants accounts for the crude revision burden 
(15%).
Drs. Schreurs and Gardeniers claimed that none 
of the following cited reports in our paper fulﬁlled 
the criteria of the NICE (2003) report at all. It must 
be noted that only the study authored by Kim et al. 
(2003) meets the NICE criteria purely. The other 
studies, however, also include important informa-
tion and deserve a closer look.
In their series of 111 THRs, Capello et al.  (2003) 
reported a 95% survival rate at 14 years for an 
HA-coated uncemented stem. The authors used an 
uncemented acetabular component, with previous 
documentation of poor performance (Manley et al. 
(1998)); again, the cup appeared to be a true failure 
with a 54% survival rate at 14 years.
McLaughlin and Lee (2000) reported results 
of 100 consecutive uncemented THRs in patients 
with a mean age of 37 years. Uncemented femoral 
components had a 98% survival rate at 12.5 years. 
The authors used a smooth-threaded uncemented 
acetabular component with previously reported 
inferior results (Tallroth et al. 1993); 56% of the 
cups were revised in the series.
In a study of 158 THRs in 141 patients aged 55 
years or younger, it was found that an uncemented 
stem showed an excellent 12-year survival rate of 
97% (Aldinger et al. 2003). In 98% of cases, the 
authors used uncemented smooth-threaded cups 
with well-documented poor results (Engh et al. 
1990, Tallroth et al. 1993, Simank et al. 1997). In the 
rest of the cases, they used cemented cups. Acetabu-
lar components had a 78% survival rate at 12 years.
Jacobsen et al. (2003) reported a 91% survival 
rate at 7.6 years for an uncemented THR. None of 
the 97 uncemented stems, however, were revised 
for aseptic loosening (98% survival rate at 7.6 
years with any stem revision as endpoint). 14 of the 
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Recently, McAuley and co-workers published 
results of 561 uncemented THRs in patients aged 
50 years or younger (McAuley et al. 2004). 10-year 
survival rates were 99% for the uncemented femo-
ral component, 90% for the uncemented acetabu-
lar component, and 89% for the THR. When liner 
exchange operations were excluded, the 10-year 
survival rate of the uncemented THR was 95%. We 
regret not noticing this excellent paper while writ-
ing the manuscript.
Kim et al. (2002) reported results of 64 hybrid 
THRs (cemented stem, uncemented cup) in patients 
aged 50 years or under; no femoral or acetabular 
component was revised because of aseptic loosen-
ing. The THR showed a 98% survival rate at 9.4 
years, with any revision as endpoint.
In a series of 118 uncemented THRs, Kim et al. 
(2003) reported a 99% 10-year survival rate with 
any revision as endpoint, and a 100% 10-year sur-
vival rate with aseptic loosening as endpoint.
To our knowledge, there has been only one report 
of cemented THRs fulﬁlling the NICE criteria in 
young patients (Keener et al. 2003).
Only a few designs comprise most of the 
cemented stems implanted in younger patients 
in our study. There were so few cemented stems 
inside different “cemented concepts”, that compar-
ing them would not have been scientiﬁcally valid. 
It is true that mean follow-up of different unce-
mented concepts varies. The Kaplan-Meier analy-
sis and the Cox regression analysis take these dif-
ferent follow-up times into account, however.
We agree with Drs. Schreurs and Gardeniers on 
one issue: the overall survival of the total implant 
is what really counts for the individual patient. 
Where interpretations of our study are concerned, 
we  disagree with our honorable colleagues. Firstly, 
one cannot generalize that outcome of THA in 
young patients is still a problem; for example, 
proximally porous-coated uncemented stems had 
a 94% survival rate at 10 years, press-ﬁt porous 
porous-coated cups had 94% survival at 10 years, 
and all-polyethylene cemented cups had 93% sur-
vival at 10 years. These results suggest that there 
are already implants on the market that work well 
in younger patients, too. It is all about choosing the 
right implants. 
Overall survival of proximally porous-coated 
or HA-coated uncemented stems was better than 
that of cemented stems with aseptic loosening as 
endpoint. When survival rates of stems are to be 
compared, in our opinion the most important end-
point is aseptic loosening; revision for any reason 
as endpoint also includes factors that are indepen-
dent of the stem design (e.g. dislocations, infec-
tion, etc.).
One should not “throw the baby out with the bath-
water”. If there is an excellent (un)cemented stem, 
which has been used with an inferior (un)cemented 
cup, the conclusion cannot be that neither of these 
components should be implanted. To the best of 
our knowledge, there have been only two studies 
published in peer-reviewed orthopedics journals in 
which both components have met the NICE crite-
ria in young patients (Keener et al. 2003, Kim et 
al. 2003). Thus, orthopedic surgeons must search 
for the best available stems and cups to be used in 
THAs on young patients. We have analyzed results 
of THR designs (also combinations) in young 
patients from the Finnish Arthroplasty Register, 
and we hope that these results will soon be avail-
able to our colleagues.
Again, we thank our colleagues for their com-
ments and their interest in this paper.
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